FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to experimental medicine, ecology and toxicology and can be used for experimental development of methods for prevention and pathogenetic correction of manifestations of chronic lead coagulopathy in experimental animals with prolonged action of lead acetate. Method involves daily administration of an antioxidant and lead acetate. Antioxidant from the first experimental day for two months, melaxen 5 mg/kg is introduced into the stomach through the probe into the stomach. Lead acetate solution is introduced in dose of 40 mg/kg in terms of metal.
EFFECT: method provides reduced pathological shifts of parameters.
1 cl, 2 tbl, 1 ex
